scholarly article | Q13442814 |
P356 | DOI | 10.1136/ARD.2008.091967 |
P698 | PubMed publication ID | 18662929 |
P50 | author | Iain McInnes | Q41687181 |
Susan S Jick | Q42946335 | ||
P2093 | author name string | L Li | |
N Sattar | |||
H Choi | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hyperlipidemia | Q1079120 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 546-551 | |
P577 | publication date | 2008-07-28 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis | |
P478 | volume | 68 |
Q37728928 | A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis |
Q49387323 | A validation study of the CirCom comorbidity score in an English cirrhosis population using the Clinical Practice Research Datalink. |
Q34344584 | Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis |
Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
Q37829385 | Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy |
Q38220638 | Defining populations at risk of rheumatoid arthritis: the first steps to prevention |
Q37690217 | Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration |
Q55515189 | Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease. |
Q33696612 | Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database |
Q34901953 | LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study |
Q38026796 | Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies |
Q35762538 | Modifiable risk factors for RA: prevention, better than cure? |
Q55305262 | PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders. |
Q52688337 | Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink. |
Q33691624 | Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study |
Q33890221 | Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation |
Q41466368 | Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment |
Q37472928 | Role for TNF in atherosclerosis? Lessons from autoimmune disease |
Q35023243 | Statin use and markers of immunity in the Doetinchem cohort study |
Q38404891 | Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study |
Q37795294 | Statins and the Joint: Multiple Targets for a Global Protection? |
Q31139441 | The Use of a Bayesian Hierarchy to Develop and Validate a Co-Morbidity Score to Predict Mortality for Linked Primary and Secondary Care Data from the NHS in England |
Q37909189 | The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review |
Q85069909 | Therapy of dyslipidemia in rheumatic diseases |
Q34411415 | Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis |
Q33867311 | Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database |
Search more.